TABLE 1.
Clinicopathological features
| Factors | SII‐ICG (n = 16) |
|---|---|
| Age, year (median (range)) | 66 (79–22) |
| Sex, male | 14 (87.5) |
| Body mass index, kg/m2 (mean ± SD) | 23.4 ± 3.6 |
| ASA‐PS | |
| ≤1 | 2 (12.5) |
| 2 | 13 (81.3) |
| ≥3 | 1 (6.3) |
| COPD | 1 (6.3) |
| Diabetes | 2 (12.5) |
| Clinical cancer stage a | |
| 0–I | 0 (0) |
| II–IV | 16 (100) |
| Pathological cancer stage a | |
| 0–I | 6 (37.5) |
| II–IV | 10 (62.5) |
| Histology | |
| Squamous cell carcinoma | 10 (62.5) |
| Adenocarcinoma | 5 (31.3) |
| Other type | 1 (6.3) |
| Neoadjuvant chemotherapy | |
| FP | 4 (25.0) |
| DCF | 9 (56.3) |
| Other | 1 (6.3) |
| No | 2 (12.5) |
| Preoperative oral intake of fat | 15 (93.8) |
| Field of lymphadenectomy | |
| Two‐field | 4 (25.0) |
| Three‐field | 12 (75.0) |
| Thoracic duct dissection | 5 (31.3) |
| Pharyngo‐laryngo‐esophagectomy | 1 (6.3) |
Note: Data are presented as n (%).
Abbreviations: ASA‐PS, American Society of Anesthesiologist Physical Status; COPD, chronic obstructive pulmonary disease; DCF, docetaxel+cisplatin+5‐FU; FP, cisplatin+5‐FU; SII‐ICG, subcutaneous inguinal injection of indocyanine green.
a
According to the definition of Japanese classification of esophageal cancer 11th edition.